Vicxone S 500mg/250mg Injection
Marketer
Renvic Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Vicxone S 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby controlling infection spread. Administration must be strictly under a physician's guidance; adhere to all scheduled doses. Complete the prescribed course regardless of symptom improvement; premature cessation can reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms immediately. Seek urgent medical attention for allergic reactions (skin rashes, itching, edema, respiratory distress). Disclose all current medications to your doctor prior to commencing treatment. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if experiencing drowsiness or dizziness. Adequate rest, nutritious food, and ample hydration are crucial for optimal recovery. Your doctor might order blood tests and other assessments to monitor treatment effectiveness.
Uses of Vicxone S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Vicxone S 500mg/250mg Injection:
Administering this medication requires a healthcare professional (doctor or nurse). Self-medication is strictly prohibited.
Common Side effects of Vicxone S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Vicxone S 500mg/250mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strongly discouraged.
How Vicxone S 500mg/250mg Injection works:
Vicxone S Injection, containing 500mg Ceftriaxone and 250mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thereby optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Vicxone S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Vicxone S, 500mg/250mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Vicxone S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Vicxone S 500mg/250mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Vicxone S 500mg/250mg Injection's application in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Vicxone S 500mg/250mg, requires careful administration in individuals with significant hepatic impairment. Dosage modification for Vicxone S 500mg/250mg Injection may be necessary. Physician consultation is advised. Altering the dose of Vicxone S 500mg/250mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Vicxone S 500mg/250mg Injection :
Omit a Vicxone S 500mg/250mg Injection dose? Seek medical advice immediately.
Facts to Know About Vicxone S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently